Ketoprofene Aguettant

Ketoprofen, the active ingredient in Ketoprofene Aguettant, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intravenous use. It is employed to relieve pain, reduce inflammation, and lower fever in patients with musculoskeletal disorders and other acute inflammatory conditions.

GNH USA supplies Ketoprofene Aguettant as a licensed, GDP‑compliant international pharmaceutical product serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support safe import and clinical use through its global distribution network.

Ketoprofen is indicated for several inflammatory and pain‑related conditions, acting primarily on musculoskeletal and febrile disorders. - Pain: Provides analgesic relief in acute and chronic pain conditions. - Inflammation: Reduces inflammatory response in musculoskeletal and postoperative settings. - Fever: Lowers elevated body temperature associated with inflammatory processes. - Rheumatoid arthritis: Alleviates joint pain and swelling in rheumatoid arthritis.

Ketoprofen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection‑site pain or erythema. - Mild rash or pruritus. - Transient elevation of liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal impairment or failure. - Severe hypersensitivity reactions, including anaphylaxis. - Hepatotoxicity with marked liver enzyme rise. - Cardiovascular events such as myocardial infarction. - Blood dyscrasias, including thrombocytopenia.

When using Ketoprofen, clinicians should consider several safety measures. - Renal function: assess baseline renal status and monitor during therapy. - Cardiovascular risk: use cautiously in patients with known heart disease. - Bleeding risk: avoid in individuals with active peptic ulcer or coagulopathy. - Pregnancy and lactation: prescribe only if benefit outweighs potential risk; safety data are limited. - Drug interactions: review concomitant medications for possible NSAID‑related interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Ketoprofen can interact with a variety of medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened ulcer risk. - ACE inhibitors or ARBs: potential for renal function decline. - Lithium: elevated lithium levels.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal clearance. - Methotrexate: decreased elimination leading to toxicity. - Antihypertensives: may blunt blood pressure control. - SSRIs: modest increase in bleeding tendency. - Oral hypoglycemics: potential alteration of glucose control.